Perrigo Company
1887
FOUNDED
PUBLIC
STATUS
10K-15K
EMPLOYEES
PRGO
STOCK SYMBOL
37
INVESTMENTS
$48.82
SHARE PRICE
(As of Thursday Closing)
Description
Perrigo is the largest store-brand over-the-counter pharmaceutical and infant formula manufacturer. The company operates three major segments: consumer healthcare, branded consumer healthcare, and prescription pharmaceuticals. As of mid-2018, Perrigo plans to divest the prescription segment. In the United States, Perrigo sells about 2,100 products with 9,000 stock-keeping units. Following the acquisition of Omega Pharma, approximately 30% of the company's revenue comes from outside the U.S.
Primary Industry
Pharmaceuticals
Stock Exchange
NYS
Primary Office
- Treasury Building
- Lower Grand Canal Street
- Dublin 2
- Ireland
+353 (01) 000 0000
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Perrigo Company’s full profile, request a free trial.
Perrigo Company Stock Performance
| 52 wk Range | Market Cap | Prev. Close | EPS | Average Volume | Shares |
|---|---|---|---|---|---|
| $36.28 - $82.95 | $6.63B | $49.86 | $0.95 | 1.26M | 136M |
Perrigo Company Financials Summary
|
In Thousands,
USD |
TTM
31-Dec-2018
|
FY 2018
31-Dec-2018
|
FY 2017
31-Dec-2017
|
FY 2016
31-Dec-2016
|
|---|---|---|---|---|
| Enterprise Value | 8,085,641 | 7,927,041 | 17,450,177 | 13,193,327 |
| Revenue | 4,731,700 | 4,731,700 | 4,946,200 | 5,280,600 |
| EBITDA | 842,200 | 842,200 | 893,000 | (4,174,700) |
| Net Income | 131,000 | 131,000 | 119,600 | (4,012,800) |
| Total Assets | 10,983,400 | 10,983,400 | 11,628,800 | 13,870,100 |
| Total Debt | 3,242,400 | 3,242,400 | 3,341,200 | 5,797,300 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
Perrigo Company Valuation and Funding
| Deal Type | Date | Amount | Post-Val | Valuation/ EBITDA |
Debt | Status |
|---|
This information is reserved for PitchBook Platform users. To explore Perrigo Company‘s full profile, request access.
Request full access to PitchBookPerrigo Company Investments & Acquisitions (37)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 00000 000000000000 | 27-Apr-2018 | 000000000 00000 00 | Buildings and Property | ||
| 00000, 000000 & 00 | 17-Aug-2016 | 000000000000000000 | Personal Products | 0000 00000000000 | |
| 0000000 0000000000 | 25-Jan-2016 | 000000000000000000 | 00000 | Pharmaceuticals | 000000 0000 |
| 00000000 000000 (0 | 31-Dec-2015 | 000000000 00000 00 | 00000 | Pharmaceuticals | 000000 0000 |
| Naturwohl Pharma | 15-Sep-2015 | Merger/Acquisition | 00000 | Distributors/Wholesale | 000000 0000 |
Perrigo Company Exits (2)
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| 000000 0000000000 | 01-Jan-2003 | 000000000000000000 | Completed |
|
|
| Vi-Jon | 01-Dec-1994 | Merger/Acquisition | 0000 | Completed |
Perrigo Company Subsidiaries (6)
| Company Name | Industry | Location | Founded |
|---|---|---|---|
| Vedants Drugs and Fine Chemicals | Pharmaceuticals | Mumbai, India | 2004 |
| 00000, 000000 & 00 | Personal Products | Peachtree City, GA | 0000 |
| 00000 000000 | Personal Products | Nazareth, Belgium | 0000 |
| 0000000 000000000 | Pharmaceuticals | Balcatta, Australia | 0000 |
| 0000000 0000000000 | Drug Delivery | Ciudad Satélite, Mexico | 0000 |
Perrigo Company Investors
| Investor Name | Investor Type | Holding | Participating Rounds | Investor Since | Board Seat | Contact Info |
|---|
This information is reserved for PitchBook Platform users. To explore Perrigo Company‘s full profile, request access.
Request full access to PitchBookPerrigo Company Executive Team (24)
12 Former Executives
You’re viewing 5 of 24 executives. Get the full list »